1. Home
  2. RAIL vs FATE Comparison

RAIL vs FATE Comparison

Compare RAIL & FATE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • RAIL
  • FATE
  • Stock Information
  • Founded
  • RAIL 1901
  • FATE 2007
  • Country
  • RAIL United States
  • FATE United States
  • Employees
  • RAIL N/A
  • FATE N/A
  • Industry
  • RAIL Railroads
  • FATE Biotechnology: Biological Products (No Diagnostic Substances)
  • Sector
  • RAIL Industrials
  • FATE Health Care
  • Exchange
  • RAIL Nasdaq
  • FATE Nasdaq
  • Market Cap
  • RAIL 121.5M
  • FATE 108.2M
  • IPO Year
  • RAIL N/A
  • FATE 2013
  • Fundamental
  • Price
  • RAIL $5.28
  • FATE $0.76
  • Analyst Decision
  • RAIL
  • FATE Hold
  • Analyst Count
  • RAIL 0
  • FATE 9
  • Target Price
  • RAIL N/A
  • FATE $5.50
  • AVG Volume (30 Days)
  • RAIL 331.5K
  • FATE 1.7M
  • Earning Date
  • RAIL 03-12-2025
  • FATE 03-05-2025
  • Dividend Yield
  • RAIL N/A
  • FATE N/A
  • EPS Growth
  • RAIL N/A
  • FATE N/A
  • EPS
  • RAIL N/A
  • FATE N/A
  • Revenue
  • RAIL $559,425,000.00
  • FATE $13,631,000.00
  • Revenue This Year
  • RAIL $7.52
  • FATE N/A
  • Revenue Next Year
  • RAIL $3.46
  • FATE N/A
  • P/E Ratio
  • RAIL N/A
  • FATE N/A
  • Revenue Growth
  • RAIL 56.22
  • FATE N/A
  • 52 Week Low
  • RAIL $3.02
  • FATE $0.75
  • 52 Week High
  • RAIL $16.10
  • FATE $7.35
  • Technical
  • Relative Strength Index (RSI)
  • RAIL 29.34
  • FATE 31.90
  • Support Level
  • RAIL $6.17
  • FATE $0.83
  • Resistance Level
  • RAIL $6.97
  • FATE $0.96
  • Average True Range (ATR)
  • RAIL 0.56
  • FATE 0.06
  • MACD
  • RAIL 0.03
  • FATE -0.00
  • Stochastic Oscillator
  • RAIL 1.31
  • FATE 2.84

About RAIL FreightCar America Inc.

FreightCar America Inc is a manufacturer of railcars and components, serving diverse transportation needs primarily in North America. The company designs and produces a wide range of railcar types, including box cars, hoppers, covered hoppers, gondolas, and flat cars for both intermodal and non-intermodal freight. Its clientele includes shippers, railroads, and financial institutions. The company has two segments: Manufacturing and Parts. The Manufacturing segment encompasses new railcar manufacturing, used railcar sales, leasing, and major rebuilds, while the Parts segment, along with corporate activities, constitutes Corporate and Other. The company's revenue is predominantly derived from its Manufacturing segment, with all revenue generated within the United States.

About FATE Fate Therapeutics Inc.

Fate Therapeutics Inc is a clinical-stage biopharmaceutical company based in the United States. It is engaged in the development of programmed cellular immunotherapies for cancer and autoimmune disorders. The company's cell therapy pipeline is comprised of NK- and T-cell immuno-oncology programs, including off-the-shelf engineered product candidates derived from clonal master iPSC lines, and immuno-regulatory programs, including product candidates to prevent life-threatening complications in patients.

Share on Social Networks: